Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)] (English, HTML)

View metadata and access the original English HTML file: Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)].

Format

HTML

Access

file-only

Publisher-reported update

2024-05-10

Health Canada reviewed the potential risk of a type of skin reaction known as subacute cutaneous lupus erythematosus(SCLE) with the use of PPIs after a published article that found these drugs may contribute to the reaction.

Access original file